Advertisement
Screener

Infinity Pharmaceuticals, Inc. Deferred Tax Assets, Net of Valuation Allowance

Add as a preferred source on Google

Infinity Pharmaceuticals, Inc. Deferred Tax Assets, Net of Valuation Allowance

Infinity Pharmaceuticals, Inc. had Deferred Tax Assets, Net of Valuation Allowance of $0 as of 2022-12-31, per its 10-K filed 2023-03-28.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance

us-gaap:DeferredTaxAssetsNet · last filed 2023-03-28

  • 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
  • 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
  • 2020-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
  • 2019-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
Period endDeferred Tax Assets, Net of Valuation Allowance
2022-12-31$0.00
10-K · filed 2023-03-28
2021-12-31$0.00
10-K · filed 2023-03-28
2020-12-31$0.00
10-K · filed 2022-03-29
2019-12-31$0.00
10-K · filed 2021-03-16
2018-12-31$0.00
10-K · filed 2020-03-03
2017-12-31$0.00
10-K · filed 2019-03-14
2016-12-31$0.00
10-K · filed 2018-03-15
2015-12-31$0.00
10-K · filed 2017-03-14
2014-12-31$0.00
10-K · filed 2016-02-23
2013-12-31$0.00
10-K · filed 2015-02-24
Advertisement